chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A few hours after the shot I went to the bathroom and had a bowel movement and peeded.  An instant burning from front to back occurred.  Water made the burning worse so I used A&D ointment for the next 24 hour period.  Within a few days I had the feeling I was moving in slow motion but my husband assured me I wasn't.  This lasted for maybe one to two weeks.  Ever since I received the vaccine for shingles, my skin, especially on portions of my back constantly itch as well as certain parts of my head, abdomen, arms, legs.  These weren't listed as any side effects but I have these problems now and it wasn't a problem before the shot.  The burning was a 24 hour thing.
Received second shot in series on 2 December 2002. On 3 December 2002 member noticed slight swelling at site with mild temperature at site. 4 December 2002 member noticed increase swelling and redness extending to elbow with associated itching ( members description of itching "Bad"). Member states that when bending arm area is tight. No visible rash.
p/vax pt broke out in itchy macular rash on arms, legs, trunk of body;reported rxn to public hlth on 10/27/99;advised DPH & avoiding vaccines containing chicken protein;
A non-serious spontaneous report of severely ill has been received from a health professional concerning an adult female, subsequent to FLUMIST. Neither relevant medical history nor concomitant medications were reported. The patient received FLUMIST in 2010. After receiving FLUMIST, the patient became severely ill for five days in 2010. The patient was not hospitalized for the event. The outcome of the event was recovered.
pt called w/ c/o fever (low grade) hot/cold flashes, achy body, rt arm felt sore & numb;
Information has been received from a physician concerning a 73 year old female with a history of breast cancer and lymphadenectomy who on 20-NOV-2006 was vaccinated SC with a 0.5ml dose of Zostavax (lot #652946/1012F). On 25-JAN-2007 the patient developed shingles. The patient has symptoms of herpes zoster 5-7 days prior to being seen. The patient also developed some edema near the lesions. The patient was seen by the physician and was treated with Valcyclovir. It was reported that the patient has had the herpes zoster in the dermatone of the lymphadenectomy and had a prolonged recovery. As of 13-FEB-2007 she may still have active lesions and was recovering. There was no product quality complaint involved. The patient's shingles and edema were considered to be disabling. Additional information has been requested.
At 1529 patient was administered MCV4 & TDAP. Patient tolerated vaccines well and was advised to wait 15 minutes in our waiting area. Within a few seconds I heard a loud noise, and saw our patient had fainted. Patient looked pale and did not respond for a few seconds before being responsive. First responders were called & patient was transferred to pediatric clinic.
Looks like chicken pox; This is a spontaneous report from a contactable consumer, the patient. A 14-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Jul2021 at 14:00 (at the age of 14-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 08Aug2021 at 08:00, the patient experienced the event which looks like chicken pox. On 09Aug2021, the patient underwent COVID-19 virus test (nasal swab) and the result was negative. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of event which included treatment with MedicRion. The clinical outcome of the event looks like chicken pox was not recovered at the time of report.
Within 5 Minutes, Numbness, tingling and pain in arm. Within 15 -30 minutes after that, numbness, Tingling and pain spread to face (forehead, cheeks, chin, nose) and to tongue. PA Prescribed Prednisone and Benedryl. After 2 doese, Pt can still not talk correctly and continues to have bilateral face pain and tingling as well as tongue and bilateral arm pain and tingling.
Patient was administered the orig. Pfizer vaccine INSTEAD of the Pfizer-Bivalent vaccine!!
Patient have large pink area around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Patient have large pink area around the injection site) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Patient have large pink area around the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Patient have large pink area around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
No additional AEs were reported; a patient received an expired VAQTA; This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. The patient's pertinent medical history, concomitant medications, drug reactions or allergies and concurrent conditions were not reported.   On 15-DEC-2021, the patient was vaccinated with hepatitis A vaccine, inactivated (VAQTA) 0.5 milliliters (ml) as prophylaxis (vaccine scheme, route of administration and anatomical site of vaccination were not reported; lot number T013204 has been verified to be valid, expiration date reported and established as 03-DEC-2021) (expired product administered). No additional adverse events were reported (no adverse event).
Employee seen 4 days after vaccination, 2 inch wide around upper arm, swollen and warm to touch. Site slightly reddened and warm to touch. No itching reported. Employee unaware of any allergies to food or drugs.
The patient reported that the adverse reaction started about 6 hours after she received the vaccination. She states that the reaction consisted of multiple symptoms: some were localized to the injection site: local swelling, redness and pain. Other symptoms were nausea, dizziness and weakness. Patient states that all of the symptoms gradually subsided within 24 hours, with the local swelling lasting the longest. Patient did not seek medical treatment for her reaction. She dropped by the Pharmacy (the location where the vaccination was given) on 10/14/18 to report to me that she had experienced a reaction. The symptoms were totally resolved at that time.
Information has been received from a physician concerning a male patient who is 20 months at present who received his first dose of ATTENUVAX, 0.5 ml SQ at 15 months old. There was no concomitant medication. It was 10-12 hours after the dose that the patient became "cranky" and his mother gave him a dose of TYLENOL. The patient's eyes rolled back in his head and he was not responding to her voice and his name. The episode lasted for several minutes. The patient then slept for hours. No fever was reported. The patient was reported to have recovered on an unknown date. The physician did mention that the mother of the patient has multiple food and medication allergies. Unspecified medical attention "phone call" was sought. No product quality complaint was involved. Additional information has been requested.
@1246 patient extremities moving uncontrollably at vaccination table while seated. Patient reported not feeling well. Clerk called for NP & observation nurse and they approached patient. EMS followed. @1249 NP and EMS assessed patient. Patient reported weakness of legs and general weakness. Hx of uncontrollable shaking occurs on first and second vaccine administration. No pallor, no SOB, no fever, no chills, no diaphoresis, no reports of dizziness, no lightheadedness, no chest pain at present, denies swelling of throat, no pain at present. Medical history of stomach ulcers and thyroid nodules. No hx of anxiety. Medications: Lasix for water retention, sulfa drug, Lipitor. Reports taking 2 tylenol before coming. sp02 100 HR 98 BP 118/77 HR 91. @1253 shaking subsides momentarily , reports chest pain, w/ history of costochondritis  @1256 EKG assessment by EMS, NP evaluated, patient with normal sinus rhythm @1259 patient still seated, sp02 100%, POD Director called 911  @1300 stroke eval, no facial drooping, strength in hands despite shaking, EMS did 12 lead EKG with normal sinus rhythm. Patient eyes closed able to speak and converse.  @1300 chest pain 9/10, uncontrollable moving comes and goes, pain does not spread, bp 122/81 HR 95  @1304 sp02 100%, supplemental o2 provided on 2L by EMS, patient reports pain feels like stabbing on external chest, reports experiences chronic pain of chest, eyes closed and reports eyelids feel heavy, was able to open eyes on request  @1309 uncontrollable movements present, paramedics arrived, NP endorsed care to paramedics and was taken to the Hospital.
APPROXIMATELY 22 HOURS AFTER VACCINATION, THE PTS MOTHER NOTED A RASH ON THE PTS LEGS.  INITIALLY THE RASH WAS ITCHY.  We saw the pt in the office about 24 hours after the dose was given and he had scattered approx 5mm red papules on his trunk.  They had white halos surrounding the erythema.  No vesicles or scabs were noted.  No fever.  The child had no further itching.  the child had had a varivax vaccine on 5/14/98 at 12 months of age without any problem.  But I do note in his chart that he was treated for a diagnosis of allergic respiratory symptoms one week after this initial varicella vaccine on 5/21/98.  He was noted to have rhonchi and a pink right TM.  He was treated with rondec syrup and given albuterol syrup prn.
area is red and warm to touch; swelling on the injection site of the patients' arm that looked like a tick bite or a bullet; It also itched in the beginning but is now light pink; area is red and warm to touch; Initial information received on 21-Apr-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves 3 patients of an unknown demographics who experienced area is red and warm to touch, swelling on the injection site of the patients' arm that looked like a tick bite or a bullet, it also itched in the beginning but is now light pink after receiving vaccine yellow fever vaccine [YF-VAX].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect yellow fever vaccine - Solution for injection strength, dose, expiry date; not reported lot number not reported via unknown route in unknown administration site for prophylactic vaccination (immunization).  On an unknown date the patient developed a non-serious area is red and warm to touch (vaccination site warmth) (vaccination site erythema), swelling on the injection site of the patients' arm that looked like a tick bite or a bullet (vaccination site swelling), it also itched in the beginning but is now light pink (vaccination site pruritus) (unknown latency) following the administration of yellow fever vaccine.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the events swelling on the injection site of the patients' arm that looked like a tick bite or a bullet, area is red and warm to touch, It also itched in the beginning but is now light pink.  At time of reporting, the outcome was Unknown for the event swelling on the injection site of the patients' arm that looked like a tick bite or a bullet, area is red and warm to touch, It also itched in the beginning but is now light pink.
Get heat rash, not fun; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of heat rash in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced heat rash (Verbatim: Get heat rash, not fun).The outcome of the heat rash was not reported.   It was unknown if the reporter considered the heat rash to be related to Shingles vaccine.  It was unknown if the company considered the heat rash to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 09-MAR-2023 This case was reported by a patient via interactive digital media. The patient got both of his/her shingles shots.  The patient got heat rash which was not fun. The follow up would not possible as no contact details were available.
Patient called physician about localized swelling no pain or fever. No treatment was given. Office visit offered patient didn't come in. Occurred next day lasted several days.
After each dose: low grade fever  99.5-100.5 for 36 hours, heavy fatigue  Second dose chills, fever  100.5
Mouth stroke; Speech affected; Tired; Little soreness at the injection site; A spontaneous report was received from a consumer concerning a 68-year old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced mouth stroke/dyskinesia, speech affected/dysarthria, little soreness at injection site/vaccination site pain and tired/fatigue.  The patient's medical history mentions history of diabetes. Concomitant medications were not provided.  On 25 Feb 2021, approximately 16 days prior to the onset of the events, the patient received the first of the two planned doses of mRNA-1273 (Batch number: 012A21A) intramuscularly for prophylaxis of COVID-19 infection.   On 12 Mar 2021, reporter mentions that apart from having a little soreness at the injection site, the patient had to stay in bed all day, was tired and her speech was affected. Reports she is much better, but the doctors confirmed that she had symptoms of a mild stroke and mouth stroke.  Treatment information was not provided. Lab tests were not provided.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events, mouth stroke, speech affected, little soreness at injection site and tired, were considered resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Received the 2nd vaccine in left arm.  Had typical not Initial feeling of fatigue, sore back and swollen lymph nodes in clavicle and underarm.  On May 14th noticed the lymph node behind my right ear was very tender, by morning of 5/17 noticed some swollen knots on top of head and small rash on right side of forehead and right eyelid.  Was given Doxycycline for infected cyst (knots on head).  By 5/19 rash had became more inflamed and lymph node in front of the ear was swollen.  Started Valtrex at home in case it was shingles.  Went to the doctor on 5/20 - prescribed additional Valtrex and prednisone.  Swelling has gone down,rash and blisters on eyelids are smaller.  Still recovering.
Flamed where patient got the shot; Red where patient got the shot; rush where patient got the shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INFLAMMATION (Flamed where patient got the shot), VACCINATION SITE ERYTHEMA (Red where patient got the shot) and VACCINATION SITE RASH (rush where patient got the shot) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No medical history was provided by the reporter. .  Concomitant products included ROSUVASTATIN, LEVOTHYROXINE, LOSARTAN, CITALOPRAM, OMEPRAZOLE and VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced VACCINATION SITE INFLAMMATION (Flamed where patient got the shot), VACCINATION SITE ERYTHEMA (Red where patient got the shot) and VACCINATION SITE RASH (rush where patient got the shot). At the time of the report, VACCINATION SITE INFLAMMATION (Flamed where patient got the shot), VACCINATION SITE ERYTHEMA (Red where patient got the shot) and VACCINATION SITE RASH (rush where patient got the shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitantly, patient was taking sirotto, mecorlol, aifil, ceramal, and cametaiane. No treatment related information has been reported.    Reporter did not allow further contact
fatigue, dizziness, chills, weakness Narrative: Patient began experiencing adverse events (fatigue, dizziness, chills, weakness) the same day as receiving vaccine
very very sick; pains in her chest like nothing I've ever felt before; she couldn't breathe; she was so cold; her body ached so bad; fever; changed pajamas three times due to sweating; This is a spontaneous report from a contactable consumer(patient) reported for herself that: A 54-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 12Mar2021 at 18:05 as single dose for covid-19 immunisation. Medical history included penicillin allergy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Patient's Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on unspecified date as single dose for covid-19 immunisation and experienced the events I was very very very sick, splitting headaches, chills, aches, freezing and she has a 102 fever. Patient reported she received her 2nd dose Friday on 12Mar2021 night at 18:05 and on Saturday 13Mar2021 at approximately noon, she became very very sick from the vaccine. She stated it was to the point that if I was at home, I would have to go to the emergency room at Medical Centre, but I was out on a soccer field refereeing. She stated that she had pains in her chest like nothing I have ever felt before. She states that she couldn't breathe, and she had to pull down her mask and try to take a deep breath. She stated It was bad later that night she reported that she was so cold, and her body ached so bad she got a fever and had to changed pajamas three times due to sweating. She stated It was bad, so there is something in that vaccine that people need to know about. She reported once the game was over and she sat down, she felt better. She stated that she has a penicillin allergy, and they believe that is the only thing that caused her to react this way. She stated Did you also know Pfizer make penicillin. Maybe there is some in the vaccine. This case assessed as non-serious by the reporter. The outcome of the events was reported as recovering.  No follow-up attempts are needed. No further information is expected.
Pt observed for 15 minutes, no immeidate reaction, notified parent of error. Mother states she was at the gym working out with pt and he was acting fine. Discussed side effects to monitor for and when seek medical attention.
AFTER PATIENT GOT FIRST DOSE OF PFIZER COVID VACCINE, PATIENT PASSED OUT AND WENT TO THE ER
High fever 104.5, 2 silent seizures. Went to ER. Gave Motrin and Tylenol around the clock every 3 hours, luke warm bath, skin to skin, breastfeeding. Fever lasted 24 hours.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Patient was nervous due to covid vaccine. -Mild, Additional Details: Emt arrived, checked patient. Patient cleared no issues.
HPI from ED: 57-year-old male with history of reactive airway disease, T2DM, OSA presenting with shortness of breath.  Patient states 2 days ago, he had to take his dog to the vet, and they accidentally ran away; he had to run "full tilt" to catch it, which caused him to become acutely short of breath.  Since then, he has had worsening difficulty breathing with any type of exertion, progressing today to dyspnea at rest.  He has been using albuterol several times per day (3-4 times today), as well as his BiPAP machine that he uses for OSA, during the day without relief.  Denies chest pain, though he has chest tightness associated with difficulty breathing.  History of similar difficulty breathing with exertion during the winter, but never this bad; has not been hospitalized or intubated for RAD.  Got his second COVID vaccine 3 days ago, after which he had fevers, now resolved.  Denies recent antibiotics; no history of COPD, slight cough today, not productive of sputum, no hemoptysis.  Reports a month of right leg swelling; has a history of prior right knee surgeries; no posterior calf pain, no acute changes; no history of VTE, no history of cancer, no hemoptysis, no recent procedures/surgeries/immobilizations.
Red spots, swelling, itching  on arm away from injection site but same arm(left). Some swelling on side of left breast and under arm.  Ongoing  Aches in hips and knees for one day.
I received my vaccine on 05/23/2022. On the morning of 06/03/2022 I woke up with a sore throat, coughing, diarrhea, feverish and fatigue. I felt as if I didn't have much of a voice. I tested positive for COVID on 06/05/2022. I contacted my doctor on Sunday and was prescribed a five day treatment of Paxlovid. The symptoms are on going.
No adverse problem- Pt was given DTAP Tripedia U2397BA instead of Td with pertusis- was told revaccination not needed.
Information has been received from a medical assistant referring to multiple patients of unknown age and gender. No relevant medical history or concurrent conditions were reported. On unknown dates the patients were vaccinated with improperly stored ZOSTAVAX (lot # L016283, expiration date 07-AUG-2016; dose and route not reported). No adverse effects were reported. Additional information has been requested.
skin breakouts on the V neck area their shoulder back, and around the foot inside of their elbow; itchy; scally; it's bumpy; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of RASH (skin breakouts on the V neck area their shoulder back, and around the foot inside of their elbow), PRURITUS (itchy), SKIN EXFOLIATION (scally) and PAPULE (it's bumpy) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included METOPROLOL, AMLODIPIN [AMLODIPINE], ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]), ALPRAZOLAM, NAPROXEN SODIUM (ALEVE), VITAMIN D3, VITAMIN B12 [VITAMIN B12 NOS], ATORVASTATIN, ORLISTAT (LINESTAT) and FOLIC ACID for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced RASH (skin breakouts on the V neck area their shoulder back, and around the foot inside of their elbow), PRURITUS (itchy), SKIN EXFOLIATION (scally) and PAPULE (it's bumpy). At the time of the report, RASH (skin breakouts on the V neck area their shoulder back, and around the foot inside of their elbow), PRURITUS (itchy), SKIN EXFOLIATION (scally) and PAPULE (it's bumpy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment details were provided.
Thursday I thought I had a little pimple on my face and went o work next day I felt sensation and I knew what it was. I went to doctor I knew it was shingles, I could feel nerves firing. They gave Valtrex and I had a steroid shot in the office.